XP Xie, W Yang, L Zhang, HQ Wang - Current Bioinformatics, 2022 - ingentaconnect.com
Background: Only 30-40% of non-small cell lung cancer (NSCLC) patients are clinically
sensitive to cisplatin-based chemotherapy. Thus, it is necessary to identify biomarkers for …